LLY compared with SLS: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

SLSSELLAS Life Sciences Group, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

SLSSELLAS Life Sciences Group, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only SLS 9

MRKMercksupplier

BMYBristol-Myers Squibbsupplier

—GenFleet Therapeutics (Shanghai)unlistedsupplier

—Memorial Sloan Kettering Cancer Center

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

5 more · SLS chain ›

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,365.65· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

SLSSELLAS Life Sciences Group, Inc.

7.84▼−14.22%· post 7.84· delayed

After hoursNov 5 '26delayed

Mkt cap$1.8BRevenue—Revenue—

Compare

After hoursNov 5 '26delayed

LLYELI Lilly & Co

SLSSELLAS Life Sciences Group, Inc.

1,371.32▼−3.29%post 1,365.65delayed

Price

7.84▼−14.22%post 7.84delayed

$1.3T

Mkt cap

$1.8B

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,371.32▼−3.29%vsSLS7.84▼−14.22%After hoursNov 5 '26delayed